These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 81730)

  • 1. alpha-Fetoprotein: studies of tumor-associated antigen cytotoxicity in mouse hepatoma BW7756.
    Mizejewski GJ; Allen RP
    Clin Immunol Immunopathol; 1978 Nov; 11(3):307-17. PubMed ID: 81730
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of murine hepatoma BW7756. II. Comparison of adult, fetal, and neoplastic liver soluble antigens.
    Mizejewski GJ; Chang G
    Neoplasma; 1978; 25(5):549-58. PubMed ID: 84344
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunobiologic studies in hepatoma-bearing mice passively immunized to alpha-fetoprotein.
    Mizejewski GJ; Dillon WR
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):655-62. PubMed ID: 94991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential association of fetal antigen with hepatoma tissue grown in vivo and in vitro.
    Higgins PJ; Tong C; Borenfreund E; Bendich A
    Eur J Cancer (1965); 1979 Apr; 15(4):423-31. PubMed ID: 86446
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antigen showing alternative to alpha-fetoprotein expression in rat hepatomas].
    Eraĭzer TL; Iazova AK; Poltoranina VS; Kuprina NI; Shipova LIa; Lunkina AB; Lazarevich NL; Abelev GI
    Biull Eksp Biol Med; 1996 Nov; 122(11):536-40. PubMed ID: 8998346
    [No Abstract]   [Full Text] [Related]  

  • 6. Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.
    Koji T; Ishii N; Munehisa T; Kusumoto Y; Nakamura S; Tamenishi A; Hara A; Kobayashi K; Tsukada Y; Nishi S; Hirai H
    Cancer Res; 1980 Aug; 40(8 Pt 2):3013-5. PubMed ID: 6156759
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of alpha-fetoprotein in rat hepatoma culture cells.
    Yoo TJ; Kuo CY; Patil SR; Kim U; Cancilla P; Ackerman LD
    Int J Cancer; 1979 Aug; 24(2):184-92. PubMed ID: 90661
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha fetoprotein: effect of heterologous antiserum on hepatoma cells in vitro.
    Mizejewski GJ; Young SR; Allen RP
    J Natl Cancer Inst; 1975 Jun; 54(6):1361-7. PubMed ID: 48552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma].
    Pang XH; Chen MS; Jia WH; Zhou XX
    Ai Zheng; 2008 Dec; 27(12):1233-8. PubMed ID: 19079985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of antisera specific for alpha-fetoprotein and mouse serum albumin on the viability and protein synthesis of cultured mouse hepatoma cells.
    Allen RP; Ledford BE
    Cancer Res; 1977 Mar; 37(3):696-701. PubMed ID: 65216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse Hepa-1 tumor is rejected by H-2Db-restricted CTL despite decreased MHC class I antigen expression.
    Nishimura MI; Ostrand-Rosenberg S
    Cell Immunol; 1991 Sep; 136(2):414-24. PubMed ID: 1908353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on 131I-labelled anti-alpha-fetoprotein antibodies in the diagnosis of rat hepatoma (author's transl)].
    Terashima H
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):122-36. PubMed ID: 6155321
    [No Abstract]   [Full Text] [Related]  

  • 13. Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens.
    Shouval D; Adler R; Wands JR; Hurwitz E; Isselbacher KJ; Sela M
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8276-80. PubMed ID: 2460865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of anti-alpha-fetoprotein antibody for radioimmunodetection: analysis with alpha-fetoprotein-secreting rat hepatoma and antigen-bound acrylic beads.
    Tanno H; Owada Y; Sato T; Koyama K; Tachibana T
    Tohoku J Exp Med; 1986 Apr; 148(4):341-51. PubMed ID: 2426842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.
    Vollmer CM; Eilber FC; Butterfield LH; Ribas A; Dissette VB; Koh A; Montejo LD; Lee MC; Andrews KJ; McBride WH; Glaspy JA; Economou JS
    Cancer Res; 1999 Jul; 59(13):3064-7. PubMed ID: 10397245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tumor incidence by oncofetal products in a syngeneic hepatoma cell-spleen cell model.
    Mizejewski GJ; Macario AL
    Neoplasma; 1983; 30(1):23-34. PubMed ID: 6188067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model.
    Wang ZF; Stein R; Sharkey RM; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):869s-872s. PubMed ID: 1688735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of tumour-bearer serum to D23 hepatoma cells derived from solid tumours, ascites or in vitro cultures.
    Lando P; Gabriel J; Berzins K; Perlmann P
    Scand J Immunol; 1982 Mar; 15(3):259-66. PubMed ID: 7089487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein on human peripheral blood lymphocytes does not block complement-dependent lymphocytotoxicity.
    Ren EC; Chan SH
    Scand J Immunol; 1981 Sep; 14(3):309-13. PubMed ID: 6173919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of murine hepatoma BW7756. I. Selected biochemical properties of liver and hepatoma.
    Mizejewski GJ; Felder MR; Wimer LT; Ziegler F
    Oncology; 1979; 36(3):113-21. PubMed ID: 89649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.